Stargardt Disease synonyms

Stargardt disease, also known as Stargardt macular dystrophy or fundus flavimaculatus, is a genetic retinal condition primarily characterized by the progressive loss of central vision due to the accumulation of lipofuscin in the retinal pigment epithelium. While various historical and clinical terms exist, Stargardt disease is the universally accepted clinical term used by ophthalmologists and geneticists worldwide to describe this specific form of inherited juvenile macular degeneration.

What are the different names for Stargardt disease?

In medical literature, you may encounter several terms for Stargardt disease that reflect different historical understandings of the condition. The most common synonym is Stargardt macular dystrophy, which highlights the location of the damage in the macula. Another frequently used term is fundus flavimaculatus; historically, clinicians thought this was a distinct disorder characterized by yellow-white "flecks" in the retina, but it is now widely recognized as a phenotypic variation of the same genetic condition as Stargardt disease. Other less common, outdated, or descriptive terms include juvenile macular degeneration and ABCA4-related retinopathy, the latter being the most precise scientific description based on the underlying genetic mutation.

Why does Stargardt disease have multiple names?

The nomenclature for Stargardt disease evolved as clinical observation and genetic testing improved. Karl Stargardt first described the condition in 1909 as a form of juvenile macular degeneration. Later, the term fundus flavimaculatus was introduced to describe patients who presented with similar visual loss but different retinal appearances. It was only through decades of clinical research and the discovery of the ABCA4 gene in 1997 that the medical community realized these were manifestations of the same underlying pathology. Today, 284 members of our DiseaseMaps.org community share experiences with this condition, and consistency in terminology helps ensure that patients, researchers, and clinicians are discussing the same clinical entity.

How is the condition classified in medical systems?

Standardized medical classification systems use specific codes to ensure consistency in medical records and research. In the International Classification of Diseases (ICD-10 and ICD-11), Stargardt disease is typically categorized under hereditary retinal dystrophies. Major databases identify the condition as follows:

• OMIM (Online Mendelian Inheritance in Man): Listed as #248200 (Stargardt disease 1).


• Orphanet: Classified as ORPHA:814.


• NIH GARD: Recognizes the condition under the preferred term Stargardt disease, with fundus flavimaculatus listed as a synonym.

Which name should patients use when speaking to doctors?

Medical professionals currently prefer the term Stargardt disease. When discussing your diagnosis with specialists, using this term is the most efficient way to ensure accurate communication. If your medical records or insurance documents use the term fundus flavimaculatus, do not be concerned; it is simply an older or alternative clinical descriptor for the same condition. Using the term Stargardt disease aligns you with the latest clinical literature and the international patient community.

Next steps

• Consult with a board-certified retina specialist to discuss your specific clinical presentation.


• Request a referral to a genetic counselor to discuss ABCA4 gene mutation testing and family planning.


• Join the 284 members on DiseaseMaps.org to connect with others navigating a diagnosis of Stargardt disease.


• Monitor ongoing clinical trials at ClinicalTrials.gov for the latest research on potential gene therapies.

Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment; always consult with your physician regarding your specific health concerns.

References

• Orphanet: Stargardt disease (ORPHA:814)


• NIH Genetic and Rare Diseases Information Center (GARD): Stargardt Disease


• OMIM: Stargardt Disease 1 (MIM #248200)


• Foundation Fighting Blindness: Stargardt Disease Information